Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2025-12-24 @ 6:38 PM
NCT ID: NCT03230357
Eligibility Criteria: Inclusion Criteria: 1. Patient≥18 years old 2. Follow the doctor's advice,patients who need to be placed PICC for the first time. 3. No serious cardiovascular diseases, such as atrial fibrillation,pulmonary heart disease and other P wave abnormalities, severe heart block, etc. 4. Patients who did not participate in other clinical studies; 5. Patients who volunteer to participate the clinical study, sign the informed consent and cooperate with the clinical follow-up. Exclusion Criteria: 1. Patients who have partial deformity or scar formation 2. Patients whose puncture site were infected or damaged 3. Patients who have sclerosis or the cord like change of the vein 4. Patients have compressed vessel by tumor 5. Patients who are confirmed or suspected having infection, bacteremia, or sepsis related to the catheter 6. Patients whose size are not fit to insert the PICC 7. Patients who are confirmed or suspected sensitive to silica gel 8. Patients who have history of radiotherapy in the pre-insertion section 9. Patients who have history of venous thrombosis, trauma, or vascular surgery 10. Patients who have superior vena cava syndrome 11. Patients who were always not following up with the doctors 12. Patients who have severe peripheral edema 13. Patients who may be required a high flow of fluid infusion, hemodialysis, pacemaker, crutches or A-V fistulation \-
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT03230357
Study Brief:
Protocol Section: NCT03230357